✦ LIBER ✦

Mucopolysaccharidosis type II (Hunter syndrome): Characterization of the iduronate-2-sulphatase in MPS II skin fibroblasts

✍ Scribed by L. Petruschka; M. Zschiesche; J. Bielicki; G. Seidlitz; G. Machill; J. J. Hopwood; F. H. Herrmann

Publisher: Springer
Year: 1994
Tongue: English
Weight: 215 KB
Volume: 17
Category: Article
ISSN: 0141-8955
DOI: 10.1007/bf00735402

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of iduronate-2-sulfatase mRNA

Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II)

✍ Paul L. Crotty; Chester B. Whitley 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 420 KB

Eight unrelated patients with Hunter syndrome were investigated for expression of iduronate-2-sulfatase (IDS) mRNA by reverse transcription (RT) linked to polymerase chain reaction (PCR), or RT-PCR. The entire coding region was studied by amplification of two overlapping segments of 0.7 and 1.1 kb.

Molecular basis of mucopolysaccharidosis

Molecular basis of mucopolysaccharidosis type II: Mutations in the iduronate-2-sulphatase gene

✍ J. J. Hopwood; S. Bunge; C. P. Morris; P. J. Wilson; C. Steglich; M. Beck; E. Sc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

A number of mutations in the X-chromosomal human iduronate-2-sulphatase gene have now been identified as the primary genetic defect leading to the clinical condition known as Hunter syndrome or mucopolysaccharidosis type 11. The mutations that are tabulated include different deletions, splice-site a

The clinical phenotype of two patients w

The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II — Hunter syndrome)

✍ James E. Wraith; Alan Cooper; Margaret Thornley; Peter J. Wilson; Paul V. Nelson 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 350 KB

Two patients with a complete deletion of the iduronate-2-sulphatase (IDS) gene are described. In both patients, the resulting phenotype was that of very severe Hunter syndrome (mucopolysaccharidosis II). In addition, both had features not commonly seen in this disorder, e.g. early onset of seizures

Mutations of the iduronate-2-sulfatase g

Mutations of the iduronate-2-sulfatase gene in 12 Polish. Patients with mucopolysaccharidosis type II (Hunter syndrome)

✍ Ewa Popowska; Michaela Rathmann; Anna Tylki-Szymanska; Susanna Bunge; Cordula St 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 1 views

## Communicated by Francesco Giannelli Mucopolysaccharidosis type I1 (MI'S 11) is an X-chromosomal storage disorder due to deficiency of the lysosomal enzyme iduronate-2-sulfatase

Mutations of the iduronate-2-sulfatase (

Mutations of the iduronate-2-sulfatase (IDS) gene in patients with hunter syndrome (mucopolysaccharidosis II)

✍ Winnie Schröder; Karin Wulff; Manfred Wehnert; Günter Seidlitz; Falko H. Herrman 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Communicated by Jurgen Horsr Genomic DNA and cDNA from fibroblasts from nine unrelated German patients with X-linked iduronate-2-sulfatase (IDS) deficiency showing variable clinical manifestation were screened for point mutations and small structural aberrations. Direct sequencing revealed a splice

Mucopolysaccharidosis type II (Hunter di

Mucopolysaccharidosis type II (Hunter disease): Identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients

✍ Kazuko Sukegawa; Shunji Tomatsu; Toshiyuki Fukao; Hideki Iwata; Xiang-Qian Song; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

## Communicated by Yusuke Nakamura Mucopolysaccharidosis type If (Hunter disease) is a lysosomal storage disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. Varied clinical phenotypes of this disease have been described. To identify mutations in individual patients and to examine